PharmaShots | Incisive News in 3 Shots

Subscribe Now

Syros Pharmaceuticals

Syros Pharmaceuticals Reports the P-III (SELECT-MDS-1) Study Data of Tamibarotene for Treating Myelodysplastic Syndrome

Syros Pharmaceuticals Reports the P-III (SELECT-MDS-1) Study Data of Tamibarotene for Treating Myelodysplastic Syndrome

November 13, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us